SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-399978
Filing Date
2014-11-06
Accepted
2014-11-06 09:26:25
Documents
10
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d804229d10q.htm 10-Q 515717
2 EX-10.2 d804229dex102.htm EX-10.2 16647
3 EX-31.1 d804229dex311.htm EX-31.1 6236
4 EX-32.1 d804229dex321.htm EX-32.1 2976
  Complete submission text file 0001193125-14-399978.txt   3100735

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT epzm-20140930.xml EX-101.INS 368028
6 XBRL TAXONOMY EXTENSION SCHEMA epzm-20140930.xsd EX-101.SCH 32005
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE epzm-20140930_cal.xml EX-101.CAL 40037
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE epzm-20140930_def.xml EX-101.DEF 57137
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE epzm-20140930_lab.xml EX-101.LAB 259023
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE epzm-20140930_pre.xml EX-101.PRE 163852
Mailing Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139 617-229-5872
Epizyme, Inc. (Filer) CIK: 0001571498 (see all company filings)

IRS No.: 261349956 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35945 | Film No.: 141199107
SIC: 2834 Pharmaceutical Preparations